- Home
- STK vs THQ Comparison
STK vs THQ Comparison
Compare STK & THQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | STK | THQ |
|---|---|---|
| Founded | N/A | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Finance Companies |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 688.8M | 779.0M |
| IPO Year | 2009 | N/A |
Fundamental Metrics
Financial Performance| Metric | STK | THQ |
|---|---|---|
| Price | $50.03 | $18.84 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 50.3K | ★ 296.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.53% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $30.26 | $15.14 |
| 52 Week High | $58.46 | $20.39 |
Technical Indicators
Market Signals| Indicator | STK | THQ |
|---|---|---|
| Relative Strength Index (RSI) | 45.29 | 52.88 |
| Support Level | $47.52 | $18.33 |
| Resistance Level | $52.04 | $18.98 |
| Average True Range (ATR) | 1.53 | 0.24 |
| MACD | -0.22 | -0.01 |
| Stochastic Oscillator | 29.86 | 62.03 |
Price Performance
Historical ComparisonAbout STK Columbia Seligman Premium Technology Growth Fund Inc
Columbia Seligman Premium Technology Growth Fund Inc is a closed-end management investment company. Its investment objective is to seek growth of capital and current income. The fund invests in various sectors such as consumer discretionary, industrials, information technology and telecommunication services.
About THQ abrdn Healthcare Opportunities Fund Shares of Beneficial Interest
abrdn Healthcare Opportunities Fund is a non-diversified closed-end fund in the United States. Its investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies. The fund invests in equity and debt securities of public and private healthcare companies believed by the Fund's Adviser to have potential for above-average growth, and may invest in private companies and other restricted securities, including private investments in public equity and venture capital investments, provided these securities comprise 10% or less of Managed Assets.